Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.

Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model. Invest Ophthalmol Vis Sci. 2019 01 02; 60(1):245-254.

View in: PubMed

subject areas

Animals
Antibodies, Blocking
Antigens, CD34
Blotting, Western
Burns, Chemical
Cell Movement
Cells, Cultured
Corneal Neovascularization
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Epithelial Cells
Eye Burns
Female
Human Umbilical Vein Endothelial Cells
Humans
Immunotherapy
Limbus Corneae
Membrane Glycoproteins
Mice
Mice, Inbred BALB C
Platelet Endothelial Cell Adhesion Molecule-1
Sodium Hydroxide
Vascular Endothelial Growth Factor A

authors with profiles

Madhuri Wadehra, PhD